chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider: DO Primary Care Provider: MD Admission Date: 12/20/2022 Discharge Date:  12/24/2022 COVID positive 12/20/2022  PRESENTING PROBLEM: Hyponatremia [E87.1]   HOSPITAL COURSE: 92 y/o F was admitted for hyponatremia and acute on chronic systolic heart failure.  The patient was incidentally COVID 19 positive.     The patient's sodium slowly and appropriately improved.  The etiology was hypervolemia and heart failure.  The sodium was stable despite the diuretics and lack of sodium tablets.  The patient will have repeat labs in 4 days.     Her congestive heart failure improved with diuresis.  The patient will go to facility on her home regimen as described above, including Metoprolol, Lasix 20 mg daily   Patient was medically stable for discharge home.  Her dementia was not associated with any behavior disorders.  She was seen by PT who said that the patient's activity level is at her baseline and that she was safe to return living facility.  I witnessed her transfers, and she appears steady.   Her family will transfer her back to living facility today, severe weather permitting.
That night I started running fever of 105, I had terrible body aches, I was in absolute misery. That lasted about 48 hours. My eyes got very dry, and I had blurred vision. I went to my eye doctor because my vision was hazy, he said my vision did look like it was all over the place and changing, so he referred me to a specialist. I saw the specialist and he confirmed my vision was changing constantly and said I needed to see an ophthalmologist, so he referred me. I had all eye tests done that you can think of. The ophthalmologist confirmed my vision is constantly changing. He told me under no circumstance that I should get the booster shot. I am having photosensitivity, I am having double vision top and bottom, I am having floaters in my eyes constantly. The doctor started me on eye drops to see if that would help any (4x's a day, daily). The drops have helped with the dryness so far. I must drive with sunglasses at night and wear them all the time because my eyes are so sensitive to the light.
The first dose I experienced flu symptoms with a body ache/chills/headache that lasted for about 2-3 days.  2nd dose, next day had a fever/chills/headache/body aches, a few days later experienced shortness in my breath, numbness, and pain in both legs, extreme lower back pain and abdominal pain/cramping and the pain is still there, I have 2 swollen lymph nodes located in my groin area. I have seen the Dr a few times and had a CT scan. They discovered I have an enlarged liver/swollen spleen that they found a blood clot, the doctor has me taking aspirin for 3 months, and will need to follow up with another CT scan
5 hrs after the vaccine when she was driving she couldn't remember where she was going and she couldn't remember the year.  It lasted about 45mins. Slight fever in the night and her mind get foggy.
The pt experienced Lyme disease symptoms. Chronic arthritis, significant joint and muscle pain. Lightheadedness, blurred vision, memory loss, slurred speech and sleep disorder. The pt has constant stiffness.
A non-serious spontaneous report of administered one dose of expired FLUMIST was received from a health professional concerning a 13-year-old male. Neither past medical history nor concomitant medications were reported for this patient. The product expired on 29-Dec-2010. On 30-Dec-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
tightness in chest; upper back discomfort; tingling in right leg from calf to toes; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 71-years-old female patient received bnt162b2 (BNT162B2 Formulation: Solution for injection), via an unspecified route of administration, administered in Arm Right on 10Feb2021 12:00 (Batch/Lot Number: EL9267) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included alendronate sodium, calcium, colecalciferol (D3) taken for an and eicosapentaenoic acid ethyl ester (VASCEPA) taken for an unspecified indication, start and stop date were not reported. The patient previously took statins and experienced drug hypersensitivity, aspirin (acetylsalicylic acid) and experienced drug hypersensitivity. No vaccination to covid prior and not covid tested post vaccination. The patient experienced tingling in right leg from calf to toes on 10Feb2021, tightness in chest and upper back discomfort on 10Feb2021 19:00. No treatment received for events. The outcome of the events tightness in chest and upper back discomfort was resolved on 10Feb2021 21:00 and other event tingling in right leg from calf to toes resolved on an unspecified date.  No follow-up attempts are possible. No further information is expected.
I had a breakthrough case. I got my 4th dose on 05/25/2022 and was fine until 6/12/2022. I started feeling bad so took a home COVID test and it came back positive.
Strong pain at injection site during the full injection. Continued pain still. Pain runs from injection site of front for arm down to left thumb, sometimes sharp pain. Have weakness and pain in shoulder, bicep and hand. Continues.
Metallic taste immediately following injection that lasted about 24 hours; Headache and nausea with vertigo; Headache and nausea with vertigo; Headache and nausea with vertigo; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration in the left arm on 27Jul2021 at 15:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic Epstein-Barr virus infection, osteonecrosis, hyperacusis, supraventricular tachycardia and allergy to latex, contrast dye, PCN, Sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the left arm on 25Jun2021 at 17:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation and took cefalexin (KEFLEX) on an unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Jul2021 at 15:30, immediately following injection, the patient experienced metallic taste lasted about 24 hours, headache and nausea with vertigo. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste immediately following injection was resolved on 28Jul2021 and of the headache and nausea with vertigo was not resolved at the time of this report.
about 4 hours after getting vaccine patient experienced 104 degree fever, chills, shaking, aches, blurry eyes and felt delirious, this lasted one day
R-arm became increasingly red, swollen mid afternoon after injection. By 4-10-14 entire upper arm swelled, painful, warm to touch per mother. Saw PCP. Swelling increased into 4-11-14 extending beyond previously marked borders called PCP given antibiotic.
fever; sore arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (chills) and PYREXIA (fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and CHILLS (chills). On 29-Jan-2021, the patient experienced PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (chills) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
went for routine Shingrix shot (second part) had severe pain and stiffness that has lasted more than three weeks. Shot was done at Pharmacy. Pain/stiffness/Loss of strength has lasted more than three weeks and there has only been a very slight improvement
The pt received the TD booster and MMR on 3/28/00 in the same arm. No reaction. 2 days later, a 3" x 3" raised red area, warm to touch, pt denies itching or pain today. The day prior complained of tightness.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concomitant medications and drug reactions or allergies was reported. On an unknown date in 2015, an unspecified number of patients might have been vaccinated with doses of improperly stored LIQUID PEDVAXHIB, lot # K007258, expiration date 04-MAR-2017 (route of administration, doses, dose numbers not provided). LIQUID PEDVAXHIB was improperly stored exposed to temperature of 90F for 24 hours on 28-MAY-2015 and 91F for 24 hours on 29-MAY-2015. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
BLOOD PRESSURE WENT UP 165 OVER 80 VERY HIGH; RED BLOOD SPOTS; BLURRING VISON; FEELS HAZY; CRAMPS IN BACK OF LEGS; PAIN ON THE CALFS OF LEGS; SKIN BLOTCHY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced blood pressure went up 165 over 80 very high, red blood spots, blurring vison, feels hazy, cramps in back of legs, pain on the calfs of legs, and skin blotchy. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 165 over 80. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from red blood spots, and the outcome of pain on the calfs of legs, blurring vison, feels hazy, blood pressure went up 165 over 80 very high, skin blotchy and cramps in back of legs was not reported. This report was non-serious.; Sender's Comments: V0-Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
lump; muscle ache; redness; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th January 2020, the patient received the 2nd dose of Shingrix. On 11th January 2020, less than a day after receiving Shingrix, the patient experienced mass and muscle pain. On 13th January 2020, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved and the outcome of the mass and muscle pain were recovering/resolving.   The reporter considered the injection site erythema and muscle pain to be related to Shingrix. It was unknown if the reporter considered the mass to be related to Shingrix.  Additional details were provided as follows: The patient stated the site of injection developed a redness 3 days before the time of reporting.   The muscle ache and the lump had improved. The reporter did not consent to follow up.
Redness, swelling, sensitive, raised lump under the skin. I marked with a pen, and it spread more over night.
No reaction to vaccine while in clinic ER visit 2/14/22 with complaint of axillary lymphadenopathy, fever diffuse rash and joint pain starting the day after the vaccination
It kicked caller's butt when caller got hers; she was already run down and tired; The pectoralis minor muscle that runs from arm pit to chest was so tense and she couldn't get it to relax; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 (Lot number: ER8734) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MUSCULOSKELETAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "It kicked caller's butt when caller got hers"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "she was already run down and tired"; MUSCLE TIGHTNESS (non-serious) with onset 2021, outcome "unknown", described as "The pectoralis minor muscle that runs from arm pit to chest was so tense and she couldn't get it to relax". The event "the pectoralis minor muscle that runs from arm pit to chest was so tense and she couldn't get it to relax" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of muscle tightness.  Additional information: reporter (patient) stated had a weird thing happen after the first one. Patient teaches dance and pole dance requires upper body strength and arm strength. She taught a dance class the night she got her vaccine. It stretched her arms out. At one point, she is strong willed, she was not sure if it was in her head. The pectoralis minor muscle that runs from arm pit to chest was so tense and she couldn't get it to relax. She went to urgent care and they gave her a muscle relaxer. Patient thinks it was more of a life style issue instead of a vaccine issue. She knows she shouldn't have done dance the same day as the vaccine. Vaccines were given at (withheld) pharmacy. She doesn't take anything. Sometimes she takes Osteo Biflex which is a supplement. Caller clarified that she wasn't taking Osteo Biflex at the time of the vaccine. No further details provided.  Patient states her left arm is her decoration arm for balance. It is not her strong arm. Patient had also received the second dose.   No follow-up attempts are possible. No further information is expected.
Interchange of vaccine products; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 15Apr2022 as dose number unknown, single (Lot number: 056A22A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown), as dose number unknown, single (Batch/Lot number: unknown) and as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfates" (unspecified if ongoing). There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received Paxlovid from 29May2023 to 03Jun2023. Patient did not has Other medication in 2 weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300219551 same reporter/patient, different product/AE;
Case number PHEH2015US019445, is an initial spontaneous report from a pharmacist received on 29 Sep 2015. This report refers to a 68 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 157105) at a dose of 0.5 ml intramuscularly on 17 Sep 2015. It was reported that the patient received FLUVIRIN that was out of temperature range at 52 F for 25 days before administration. No adverse event was reported.
Had migraine with aura for first time in my life on 4/23, then a second on 4/29, which is one day after my second dose. Then had a third one on 5/20. Saw doctor on 5/25  to confirm it was migraines since I had never had them before.
Doses were viable up to 14April2021and Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were viable up to 14April2021and Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were viable up to 14April2021and Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On 15-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Doses were viable up to 14April2021and Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  It was reported that, the vaccine transport conditions  on 15-Mar-2021 at 6:45 am was 0.4 degrees Celsius and in between 6:45 to 7:00 am, it was -2 degrees Celsius. Vaccine was placed at freezer temperature, -20 degrees Celsius.  No treatment medication was given.
General fatigue, severe swelling in arm with pain, hives on scalp with horrible itching, diarrhea, stomach pain, severe back pain, nausea.
After the initial injection (1/11), there was just soreness at the site and no other problems.  The next morning (1/12), I woke with severe vertigo and ensuing nausea.  I couldn't focus my eyes on any one point because everything seemed to quiver.  The nausea was like motion sickness.  I couldn't walk without stumbling.  Since this was the first time I've ever experienced vertigo, it was concerning.  I consulted my sister who is an RN who recommended the Epley Maneuver.  It helped only a little, but I resigned to returning to bed to sleep to avoid the symptoms.  The next day (1/13), I woke with vertigo again.  It was not as bad as the first day, but prevented my activities (walking around the house, driving, working).  Today (1/14) I woke feeling slightly queasy, but can function, but not work.  If the resolution continues on this trajectory, I should be okay tomorrow, I hope.
Child received vaccine 10/27 DTaP and MMR. On 11/2, 11/3 and 11/4/03 cried, had T >103. No seizures or irritability. No other illness. Child seen 11/5, 11/6 with red blanching flat macular rash trunk and extremities. No petechiae.
her daughter tested positive for the COVID19; her daughter tested positive for the COVID19; This is a spontaneous report from a contactable consumer or other non-health care professional (parent) received via a Program.     A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that she tested positive for the covid19 on an unspecified date. The caller stated that she is scheduled to receive the second dose of Pfizer Biontech COVID19 vaccine tomorrow. Caller said that she tested positive for the COVID19. Caller wanted to know if it was okay to receive the vaccine as scheduled tomorrow or if they need to re-schedule it. The patient underwent lab tests and procedures which included covid-19, positive on an unspecified date. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a physician via Pfizer (MFR# 2017281821) refers to a currently 78 years old female patient. On an unknown date the patient was vaccinated with pneumococcal vaccine (manufacturer unknown) (dose, route and lot# not reported) for prophylaxis. On an unknown date the patient experienced hives. The outcome was unknown. This is one of several reports received from the same resource.; Sender's Comments: US-009507513-1707USA009007:
Varicella - Information has been received from a licensed practical nurse concerning a 9 year old female patient who on 04 Jan 1996 was vaccinated SC with a first dose of varicella virus vaccine live (lot 508578/0389b).  Subsequently the patient experienced chickenpox.  It was noted that the patient had over 100 lesions.  She was seen in the physician office to verify the actual number of lesions and the disease.  Subsequently, the patient recovered.  Additional information is not expected.
Extreme arm soreness of left arm, inability to move left arm, fever, sore back, sore knees, headache, splotches on upper left arm.